| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $31.0M | +3.9% | +80.2% |
| SG&A Expense | $14.7M | +32.4% | +93.2% |
| Operating Income | -$45.7M | -11.7% | -84.2% |
| Interest Expense | $1.3M | -45.5% | +75.2% |
| Net Income | -$67.3M | -57.4% | -391.6% |
| EPS (Basic) | -$0.78 | -56.0% | -333.3% |
| EPS (Diluted) | -$0.78 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.0M | -40.2% | -93.2% |
| Short-term Investments | $189.1M | +26.4% | — |
| Current Assets | $215.8M | +14.1% | -27.9% |
| Total Assets | $236.9M | -10.6% | -25.9% |
| Current Liabilities | $65.4M | +72.3% | +96.7% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$88.6M | — | — |
| Investing Cash Flow | -$186.6M | — | — |
| Financing Cash Flow | $21.4M | — | — |
| -56.0% |
| -188.9% |
| $40.4M |
| -2.0% |
| +66.1% |
| Total Liabilities | $106.3M | +33.4% | +84.7% |
| Stockholders' Equity | $130.6M | -29.6% | -50.2% |